학술논문

Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy
Document Type
Article
Source
In Urologic Oncology: Seminars and Original Investigations November 2023 41(11):458-458
Subject
Language
ISSN
1078-1439